ArticleTurk gogus kalp damar cerrahisi dergisi2019
Complications and management strategies of totally implantable venous access port insertion through percutaneous subclavian vein.
Article in Turk gogus kalp damar cerrahisi dergisi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.
- Comparing internal jugular vein and subclavian vein for central venous insertion of implantable ports in cancer chemotherapy: a meta-analysis of RCTs.Frontiers in oncology · 2025Pooled it
- Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.Langenbeck's archives of surgery · 2021Pooled it
- Development and validation of a machine learning model for predicting unplanned removal of totally implantable venous access ports in patients with breast cancer.Frontiers in oncology · 2026Article
- Tunnelless totally implantable venous access device implantation via ultrasound-guided axillary vein puncture: A retrospective analysis.The Journal of international medical research · 2025Article
- Ultrasound-guided axillary vein versus internal jugular vein access for totally implantable venous access ports in breast cancer: a retrospective comparison of patient-reported outcomes.Frontiers in oncology · 2025Article
- Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.BMC cancer · 2024Article
- [GMIA-Breast Oncoplastic and Reconstruction Society consensus on operative standards of breast cancer surgery].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023Article
- Rapport de cas Surgical retrieval of a migrated vascular access port catheter in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2023Article
- A rare pinch-off case embolized to the pulmonary artery.Turk gogus kalp damar cerrahisi dergisi · 2023Article
- Outcome of antithrombotic therapy in cancer patients with catheter-related thrombosis: a systematic review.Frontiers in cardiovascular medicine · 2023Review
- The Effect of a New Ligation and Venipuncture Method on Vena Basilica Vessel.Applied bionics and biomechanics · 2022Article
- Long-Term Results of a Standard Algorithm for Intravenous Port Implantation.Journal of personalized medicine · 2021Article
- Catheter allotopia with totally implantable access port: A report of three cases and literature review.Clinical case reports · 2021Article
- Does catheter material affect functional performance of intravenous ports via the superior vena cava?PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to present clinical characteristics, peri-procedural outcomes, early and late complications, and management strategies in patients undergoing totally implantable venous access port insertion through percutaneous subclavian vein.
methodsA total of 2,084 port devices were inserted to 2,000 cancer patients (1,066 males, 934 females; mean age 58.4±12.7 years; range, 18 to 88 years) through subclavian vein using percutaneous landmark method between March 2012 and June 2018. Medical data including demographic features, primary diagnosis, technical success, procedural time, duration of device use, reasons for the device removal, and early and late complications were retrospectively analyzed.
resultsThe most common type of cancer was colon cancer in males and breast cancer in females. Technical success rate of the procedure was 98.5%. Right subclavian vein was accessed in the majority of patients (92.4%). Early complications including inadvertent arterial puncture, catheter malposition, superficial hematoma, and pneumothorax occurred in 143 patients (6.9%), while late complications including infection, catheter occlusion, venous thrombosis, wound problems, catheter migration and embolization and pinch-off syndrome was developed in 118 patients (5.7%). Inadvertent arterial puncture in 63 patients (3%) was the most common early complication, while infection in 44 patients (2.1%) was the most common late complication. A total of 192 devices were removed due to the completion of chemotherapy or development of complications.
conclusionOur study confirmed the safety and tolerability of totally implantable venous access port insertion through percutaneous subclavian vein with high technical success and low complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.